SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

Nature Genetics

Volumn 41, Issue 11, 2009, Pages 1238-1242

  Bass, Adam J ^a,b,c   Watanabe, Hideo ^a,c   Mermel, Craig H ^a,c   Yu, Soyoung ^a   Perner, Sven ^b,d   Verhaak, Roel G ^a,c   Kim, So Young ^a   Wardwell, Leslie ^a   Tamayo, Pablo ^c   Gat Viks, Irit ^c   Ramos, Alex H ^a,c   Woo, Michele S ^a,c   Weir, Barbara A ^a,c   Getz, Gad ^c   Beroukhim, Rameen ^a,b,c   O'Kelly, Michael ^c   Dutt, Amit ^a,c   Rozenblatt Rosen, Orit ^a   Dziunycz, Piotr ^a   Komisarof, Justin ^a   Chirieac, Lucian R ^b   Lafargue, Christopher J ^b   Scheble, Veit ^d   Wilbertz, Theresia ^d   Ma, Changqing ^e   Rao, Shilpa ^e   Nakagawa, Hiroshi ^e,f   Stairs, Douglas B ^e,f   Lin, Lin ^g   Giordano, Thomas J ^h   Wagner, Patrick ^b   Minna, John D ⁱ   Gazdar, Adi F ⁱ   Zhu, Chang Qi ^j   Brose, Marcia S ^e   Cecconello, Ivan ^k   Ribeiro Jr, Ulysses ^k   Marie, Suely K ^k   Dahl, Olav ^l   Shivdasani, Ramesh A ^a,b   Tsao, Ming Sound ^j   Rubin, Mark A ^b   Wong, Kwok K ^a,b   Regev, Aviv ^c   Hahn, William C ^a,b,c   Beer, David G ^g   Rustgi, Anil K ^e,f   Meyerson, Matthew ^a,b,c   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d Kinderklinik Tuebingen   (Germany)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g Section of Thoracic Surgery   (Turkey)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j UNIVERSITY HEALTH NETWORK   (Canada)

^k UNIVERSITY OF SÃO PAULO   (Brazil)

^l UNIVERSITY OF BERGEN   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMOSOME 3Q; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LUNG CARCINOMA; ONCOGENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RNA INTERFERENCE;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; ESOPHAGEAL NEOPLASMS; GENE AMPLIFICATION; GENOME, HUMAN; HUMANS; LUNG NEOPLASMS; ONCOGENES; RNA INTERFERENCE; SOXB1 TRANSCRIPTION FACTORS;

EID: 70350641014     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.465     Document Type: Article

References (38)

1. Weir, B.A. et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898 (2007).
2. Garraway, L.A. & Sellers, W. Lineage dependency and lineage-survival oncogenes in human cancer. Nat. Rev. Cancer 6, 593-602 (2006).
3. Williamson, K.A. et al. Mutations in SOX2 cause anopthalmia esophageal-genital (AEG) syndrome. Hum. Mol. Genet. 15, 1413-1422 (2006).
4. Que, J. et al. Multiple dose-dependent roles for SOX2 in the patterning and differentiation of anterior foregut endoderm. Development 134, 2521-2531 (2007).
5. Que, J. et al. Multiple roles for Sox2 in the developing and adult mouse trachea. Development 136, 1899-1907 (2009).
6. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126, 663-676 (2006).
7. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
8. Wernig, M. et al. In vitro reprogramming of fbroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324 (2007).
9. Beroukhim, R. et al. Assessing the signifcance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. USA 104, 20007-20012 (2007).
10. Choi, Y.W. et al. Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung. Lung Cancer 55, 43-51 (2007).
11. Pack, S.D. et al. Molecular cytogenetic fngerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosom. Cancer 25, 160-168 (1999).
12. Massion, P.P. et al. Signifcance of p63 amplifcation and overexpression in lung cancer development and prognosis. Cancer Res. 63, 7113-7121 (2003).
13. Woenckhhaus, J. et al. Genomic gain of PIK3CA and increased expression of p110α are associated with progression of dysplasia into invasive squamous cell carcinoma. J. Pathol. 198, 335-342 (2002).
14. Sarkaria, I. et al. Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplifcation in squamous cell carcinomas. Cancer Res. 66, 9437-9444 (2006).
15. Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227 (2009).
16. Ebert, B.L. et al. Identifcation of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 451, 335-339 (2008).
17. Luo, B. et al. Highly parallel identifcation of essential genes in cancer cells. Proc. Natl. Acad. Sci. USA 105, 20380-20385 (2008).
18. Lundberg, A.S. et al. Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 21, 4577-4586 (2002).
19. Raponi, M. et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res. 66, 7466-7472 (2006).
20. Gudmundsson, J. et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 41, 460-464 (2009).
21. Dathan, N., Parlato, R., Rosica, A., De Felice, M. & Di Lauro, R. Distribution of the titf2/foxe1 gene product is consistent with an important role in the development of foregut endoderm, palate, and hair. Dev. Dyn. 224, 450-456 (2002).
22. Clifton-Bligh, R.J. et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat. Genet. 19, 399-401 (1998).
23. Dutt, A. et al. Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc. Natl. Acad. Sci. USA 105, 8713-8717 (2008).
24. Kendall, J. et al. Oncogenic cooperation coamplifcation of developmental transcription factor genes in lung cancer. Proc. Natl. Acad. Sci. USA 104, 16663-16668 (2007).
25. Kwei, K.A. et al. Genomic profling identifes TITF1 as a lineage-specifc oncogene amplifed in lung cancer. Oncogene 27, 3635-3640 (2008).
26. Tanaka, H. et al. Lineage-specifc dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res. 67, 6007-6011 (2007).
27. Tonon, G. et al. High-resolution genomic profles of human lung cancer. Proc. Natl. Acad. Sci. USA 102, 9625-9630 (2005).
28. Shedden, K. et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med. 14, 822-827 (2008).
29. Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507 (2008).
30. Chen, X. et al. Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol. 8, 1 (2008).
31. Rock, J.R. et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl. Acad. Sci. USA 106, 12771-12775 (2009).
32. Perner, S. et al. EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia 10, 298-302 (2008).
33. Liu, H. et al. AffyProbeMiner: a web resource for computing or retrieving accurately redefned Affymetrix probe sets. Bioinformatics 23, 2385-2390 (2007).
34. Irizarry, R.A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003).
35. Huber, W. & Gentleman, R. Matchprobes: a Bioconductor package for the sequence-matching of microarray probe elements. Bioinformatics 20, 1651-1652 (2004).
36. Tusher, V.G., Tibshirani, R. & Chu, G. Signifcance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
37. Segal, E., Friedman, N., Koller, K. & Regev, A. A module map showing conditional activity of expression modules in cancer. Nat. Genet. 36, 1090-1098 (2004).
38. Santagata, S., Ligon, K.L. & Hornick, J.L. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am. J. Surg. Pathol. 31, 836-845 (2007).